These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6092416)

  • 1. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells.
    Tuomanen EI; Zapiain LA; Galvan P; Hewlett EL
    J Clin Microbiol; 1984 Aug; 20(2):167-70. PubMed ID: 6092416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Lima L; Molina MDGF; Pereira BS; Nadaf MLA; Nadaf MIV; Takano OA; Carneiro-Sampaio M; Palmeira P
    Vaccine; 2019 May; 37(19):2569-2579. PubMed ID: 30955978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic findings in oral pertussis vaccination].
    Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
    Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine.
    Redd SC; Rumschlag HS; Biellik RJ; Sanden GN; Reimer CB; Cohen ML
    J Clin Microbiol; 1988 Jul; 26(7):1373-7. PubMed ID: 2900846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of antibody against Bordetella pertussis in whooping cough patients, healthy children and newborn infants. IgG, IgM and IgA antibody responses determined by enzyme-linked immunosorbent assay].
    Miyata Y; Katsukawa C; Tanaka I; Harada K
    Kansenshogaku Zasshi; 1983 Jan; 57(1):7-16. PubMed ID: 6304209
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells.
    Tuomanen E; Weiss A
    J Infect Dis; 1985 Jul; 152(1):118-25. PubMed ID: 2861240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis.
    Pereira A; Pietro Pereira AS; Silva CL; de Melo Rocha G; Lebrun I; Sant'Anna OA; Tambourgi DV
    Am J Trop Med Hyg; 2010 Apr; 82(4):678-82. PubMed ID: 20348518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
    Nagel J; de Graaf S; Schijf-Evers D
    Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
    Isacson J; Trollfors B; Taranger J; Lagergård T
    Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection.
    Dolby JM; Stephens S
    J Hyg (Lond); 1973 Mar; 71(1):193-207. PubMed ID: 4348456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.